UNRAVELING THE CONNECTION: INFLAMMATORY MARKERS AND DIABETES MELLITUS PATHOGENESIS

Descargar Publicación
Research progress on oral glucagon-like peptide-1 receptor agonists in the treatment of diabetes mellitus type 2 Roche posiciona al CT-388 como un competidor clave frente a tirzepatida